Lichen planus is driven by the immune system turning against the body’s own skin and mucous membrane cells, but the reasons the immune system misfires in the first place vary from person to person. In most cases, a specific type of white blood cell targets and kills keratinocytes, the cells that form the outer layers of skin and the lining of the mouth. What sets off that attack can be a viral infection like hepatitis C, a medication, a contact allergen, psychological stress, or genetic predisposition, and often it is some combination of these acting together. Understanding the interplay of these triggers helps explain why lichen planus behaves so differently across individuals and why it can be so difficult to treat.
The Core Mechanism Is an Immune Attack on Skin Cells
Whatever the initial trigger, the damage in lichen planus follows a consistent pattern. A specific class of immune cells, CD8-positive T cells, infiltrates the lowest layer of the skin or mucous membrane and kills the keratinocytes there. Early research using electron microscopy showed that these T cells release a protein called granzyme B directly onto neighboring keratinocytes, triggering those cells to self-destruct through a process called apoptosis.1PubMed. The role of granzyme B-expressing CD8-positive T cells in apoptosis of keratinocytes in lichen planus This cell-killing mechanism is essentially the same one the immune system uses to destroy virus-infected cells or cancer cells, except in lichen planus it is misdirected against healthy tissue.
The attack does not stop with direct cell killing. The invading T cells also release inflammatory signaling molecules. Research on erosive oral lichen planus found that tissue-resident memory T cells in the affected area pump out elevated levels of interferon-gamma, TNF-alpha, and interleukin-17, all of which amplify inflammation and recruit even more immune cells to the site.2PubMed Central. CD8(+) tissue-resident memory T cells induce oral lichen planus erosion via cytokine network Studies measuring these molecules in saliva have confirmed that their levels track with disease severity: the worse the lesions, the higher the concentrations of TNF-alpha and related cytokines.3PubMed Central. Salivary cytokine profile in patients with oral lichen planus When patients receive treatment with corticosteroids, those inflammatory markers drop significantly, which confirms they are not just bystanders but active drivers of the disease.4PubMed Central. Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus
Why the Immune System Targets Its Own Cells
If the T cells are the weapon, the question becomes: what aims them at the wrong target? One leading hypothesis centers on heat shock proteins. These are molecules that cells produce when they are stressed by heat, infection, toxins, or other insults. In lichen planus, keratinocytes appear to ramp up production of certain heat shock proteins, particularly one called HSP60. Research has found that HSP60 expression in the basal layer of affected tissue is significantly higher than in healthy tissue.5PubMed. Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis Studies comparing both skin and oral lichen planus to normal tissue have confirmed overexpression of HSP60 and HSP70 genes in both forms of the disease.6PubMed Central. Evaluation of the Altered Tissue Expression of HSP60 and HSP70 Genes in Oral and Cutaneous Lichen Planus Compared to Normal Healthy Tissues
The idea is that diverse stressors, whether a virus, a drug, a dental material, or psychological tension, push keratinocytes to display these stress proteins on their surfaces. The immune system then interprets the stressed cells as abnormal or dangerous and sends T cells to eliminate them.7PubMed. Heat shock protein expression in oral lichen planus This framework helps explain one of the most puzzling features of lichen planus: why such different triggers, from a virus on one continent to a blood pressure pill on another, can all produce the same distinctive rash or mouth sore. They may all converge on the same pathway of keratinocyte stress and immune recognition.
The Hepatitis C Connection
The strongest and most studied viral link to lichen planus involves hepatitis C. A large meta-analysis pooling data from 45 studies found that people with lichen planus were roughly four and a half times more likely to test positive for hepatitis C antibodies compared to people without the condition.8PubMed. Lichen planus is associated with hepatitis C but not with hepatitis B virus: a systematic review and meta-analysis with a focus on Italian data That is a substantial association, but it comes with a major geographic caveat. The link is strongest in Mediterranean countries and parts of Asia, where hepatitis C itself is more common. In northern Europe, the association essentially disappears. One study from Saudi Arabia found hepatitis C antibodies in about a quarter of lichen planus patients, compared to under five percent of controls.9PubMed Central. Association of lichen planus with hepatitis C virus infection
The geographic variation is not just a quirk of statistics. It likely reflects both the local prevalence of the virus and differences in the genetic makeup of affected populations.10PubMed Central. Association of oral lichen planus with chronic C hepatitis. Review of the data in literature The prevailing explanation is that hepatitis C creates a particular pattern of immune dysfunction that, in genetically susceptible people, tips the immune system into attacking its own tissues. Hepatitis C is not a direct cause of lichen planus in the way that a bacterium causes strep throat. Instead, the virus appears to create conditions where the autoimmune process is more likely to ignite. Hepatitis B, by contrast, does not show the same association.8PubMed. Lichen planus is associated with hepatitis C but not with hepatitis B virus: a systematic review and meta-analysis with a focus on Italian data
HPV and Other Viral Suspects
Hepatitis C gets most of the attention, but human papillomavirus has also come under scrutiny. A meta-analysis of case-control and cross-sectional studies found that people with HPV infection had at least roughly double the odds of having oral lichen planus, with some analyses putting the number higher.11PubMed Central. Human Papillomavirus in Oral Lichen Planus: Is There an Association? A Meta-Analysis Whether HPV plays a causal role, contributes to disease progression, or simply co-occurs in inflamed tissue remains unclear. The relationship is plausible on biological grounds since HPV infects the same epithelial cells that lichen planus destroys, but researchers are still sorting cause from coincidence.
COVID-19 vaccination has also been reported as an occasional trigger. Case reports describe lichen planus appearing after both mRNA-based and adenovirus-vector vaccines.12PubMed Central. Lichen planus triggered by COVID-19 vaccination: A case series 13PubMed Central. Oral lichen planus arising after BNT162b2 mRNA COVID-19 vaccine: report of 2 cases A narrative review collected 61 such cases from the literature.14PubMed. Lichen planus following COVID-19 vaccination: a narrative review Given the billions of doses administered worldwide, 61 cases is a tiny number, and the link remains at the level of case reports rather than established causation. The most likely explanation is that vaccination, like any strong immune stimulus, can unmask a latent autoimmune tendency in a small number of predisposed people.
Medications That Mimic Lichen Planus
Certain drugs can produce skin eruptions that look nearly identical to lichen planus. These lichenoid drug eruptions are considered a distinct condition from spontaneous lichen planus, but the clinical and microscopic resemblance is so close that telling them apart can be difficult even for dermatologists. The eruptions typically appear as symmetrical, violet-colored bumps and patches, mainly on the arms and legs.
The specific drugs most commonly responsible depend partly on the patient population being studied. A large review of published cases found that immune checkpoint inhibitors, used in cancer treatment, were the most frequently reported culprits, followed by tyrosine kinase inhibitors (another class of cancer drug) and anti-TNF antibodies used for autoimmune diseases.15PubMed. Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications In a 17-year hospital-based study that focused more on everyday medications, calcium channel blockers (used for high blood pressure) topped the list, accounting for over forty percent of cases, followed by statins.16PubMed Central. Clinicopathological Characteristics of Lichenoid Drug Eruption: A 17-Year Retrospective Study Another clinical study likewise identified blood pressure drugs as the leading cause, with tuberculosis medications coming in second.17PubMed Central. Clinical Profile of Patients with Lichenoid Drug Eruption: A Observational Study
One of the telltale features of drug-induced cases is the delay between starting a medication and developing symptoms. This latency period can range from a couple of weeks to well over a year, with median times around two to four months in most studies.17PubMed Central. Clinical Profile of Patients with Lichenoid Drug Eruption: A Observational Study That long gap is part of what makes diagnosis tricky: people rarely connect a rash that starts in August with a pill they began taking in March. After the offending drug is stopped, lesions typically clear within weeks to a few months when combined with topical steroid treatment, though some cases are slower to resolve.16PubMed Central. Clinicopathological Characteristics of Lichenoid Drug Eruption: A 17-Year Retrospective Study
Dental Materials and Contact Triggers
For oral lichen planus specifically, something sitting right against the tissue can be the culprit. Amalgam dental fillings, which contain mercury, are the most studied example. Research has shown that contact allergy to mercury compounds plays a meaningful role in some oral lichen planus cases, particularly when the lesions appear on tissue directly touching an amalgam restoration and when there is no simultaneous skin involvement. In patients who tested positive for mercury allergy on patch testing, replacing the amalgam fillings led to significant improvement in nearly all cases.18PubMed. Oral lichen planus and allergy to dental amalgam restorations
This does not mean amalgam fillings cause lichen planus broadly. The effect is limited to individuals who develop a specific contact sensitivity to mercury. For the majority of people with amalgam fillings, there is no connection. But for someone with oral lichen planus lesions sitting right next to a filling, it is worth discussing patch testing with a dentist or dermatologist.
The Role of Stress and Oxidative Damage
Clinicians who treat lichen planus have long noticed that flares often coincide with periods of psychological stress. Recent laboratory work offers a plausible explanation. A study examining the effects of epinephrine (the stress hormone released during the body’s fight-or-flight response) on keratinocytes found that the hormone binds to receptors on these cells and triggers a cascade that produces reactive oxygen species, the same type of cellular damage involved in aging and many chronic diseases. The resulting oxidative stress then activates inflammatory signaling pathways and causes the cells to release “danger signals” that attract immune cells to the area.19PubMed Central. Epinephrine as a potential driver of oral lichen planus pathogenesis
The oxidative stress angle extends beyond the stress-hormone pathway. Multiple studies have measured markers of oxidative damage in lichen planus patients and consistently found elevated levels of a molecule called MDA, which indicates that cell membranes are being broken down by free radicals, alongside reduced antioxidant defenses.20PubMed Central. Oxidative Stress in Cutaneous Lichen Planus—A Narrative Review 21Indian Journal of Public Health Research & Development. Evaluation of Oxidative stress using Superoxide Dismutase and Lipid Peroxidation in Lichen Planus: A Tissue Level Enzymatic Analysis Study This fits the broader picture of lichen planus as a disease where multiple stressors, psychological and cellular alike, can push keratinocytes past a threshold where the immune system begins to view them as threats.
Genetic Susceptibility
Not everyone exposed to the same triggers develops lichen planus, and genetics help explain why. The most consistent genetic associations involve genes in the human leukocyte antigen (HLA) system, which governs how the immune system identifies which cells belong to the body and which do not. One study in a Mexican population found that a particular HLA variant, DRB1*0101, was associated with more than five times the odds of developing lichen planus compared to controls.22PubMed. HLA-DRB1*0101 is associated with the genetic susceptibility to develop lichen planus in the Mexican Mestizo population A more recent fine-mapping study in a Finnish population found that the same DRB1*01:01 allele, along with closely linked variants, showed the strongest association with lichen planus overall, while certain other HLA types appeared to be protective.23medRxiv. Fine mapping of HLA effects in Oral and non-Oral lichen planus
The fact that these HLA associations show up in geographically and ethnically distinct populations suggests a genuine biological link rather than a statistical fluke. The HLA system shapes which protein fragments the immune system surveys and reacts to, so carrying particular HLA variants could make a person’s immune system more likely to recognize stressed keratinocytes as targets. Think of it as having an immune fingerprint that makes you more susceptible to this particular misfire, though the trigger still has to come from somewhere.
The Oral Microbiome as a Contributing Factor
A growing body of research has examined whether the bacterial communities living in the mouth play a role in oral lichen planus. The evidence consistently shows that patients with oral lichen planus have a disrupted microbiome compared to healthy individuals. Beneficial bacteria normally found in the mouth, like certain streptococcus and rothia species, tend to be reduced, while bacteria associated with gum disease and inflammation, including fusobacterium and prevotella species, are frequently more abundant.24PubMed Central. Oral Microbiome Research on Oral Lichen Planus: Current Findings and Perspectives A systematic review confirmed this pattern across multiple studies, noting that the shifted bacterial populations contribute to immune activation and disruption of the epithelial barrier.25Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. The role of oral microbiome in the pathogenesis of oral lichen planus: A systematic review
Whether this microbial shift is a cause, a consequence, or a self-reinforcing feedback loop remains one of the open questions. Inflamed, damaged tissue creates a different environment for bacteria, so the disease itself could reshape the microbiome. But certain bacterial products, like lipopolysaccharide from gram-negative species, are known to activate the same inflammatory pathways seen in lichen planus, raising the possibility that microbial dysbiosis helps sustain the disease even after the original trigger is gone.
Autoimmune Overlap and Comorbidities
Lichen planus rarely exists in isolation. Retrospective studies have found significant associations between lichen planus and a range of other autoimmune conditions, including vitiligo, alopecia areata, lupus, Sjögren syndrome, autoimmune hepatitis, and autoimmune thyroiditis.26PubMed. Lichen planus autoimmune comorbidities: A retrospective case-control study A study focused specifically on lichen planopilaris, the form that affects hair follicles, found a notable association with Hashimoto’s thyroiditis and hypothyroidism.27PubMed Central. Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients This clustering suggests that the same underlying immune predisposition that leads to lichen planus may also push toward other autoimmune diseases in the same individual.
Another concern that comes up frequently is whether oral lichen planus can become cancerous. The World Health Organization classifies it as a potentially malignant disorder, and the chronic inflammation it causes has features that overlap with some of the biological hallmarks associated with tumor development. A scoping review of systematic reviews found that the most commonly studied overlap was tumor-promoting inflammation, identified in 85 percent of the reviews examined.28PubMed Central. Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses The estimated malignant transformation rate is low, generally reported in the range of one to two percent over many years, but it is the reason that oral lichen planus patients are typically advised to have regular follow-ups.
Who Is Most Affected
Lichen planus affects roughly 0.15 percent of the adult population based on age- and sex-standardized estimates, and it is about 1.8 times more common in women than in men.29Journal of the American Academy of Dermatology. Prevalence and treatment patterns of lichen planus The prevalence rises with age, peaking in the 70-to-79 age group and remaining uncommon in young adults. A Polish clinical series similarly found that women made up nearly seventy percent of oral lichen planus patients, with the majority aged between 56 and 75.30PubMed Central. Oral Lichen Planus: Clinical Presentation, Demographic Characteristics, and Risk Factors in a Retrospective Study of 186 Polish Patients
Interestingly, prevalence does not appear to vary dramatically across racial groups, with similar rates in white, Asian, and other populations in standardized analyses.29Journal of the American Academy of Dermatology. Prevalence and treatment patterns of lichen planus That said, the specific triggers that predominate do vary by region, as the hepatitis C data illustrate. Different subtypes also behave differently. Treatment outcomes and comorbidity profiles vary substantially depending on whether the condition affects skin, mouth, hair follicles, nails, or genitals, underscoring that “lichen planus” is really an umbrella term covering several related but distinct clinical presentations.31PubMed Central. Evaluation of Comorbidities and Treatment Outcome in Various Subtypes of Lichen Planus: A Single-Center Retrospective Study
Why Spontaneous Resolution Varies So Widely
One of the practical implications of having so many potential causes is that the disease course depends heavily on which trigger is involved. Skin lichen planus resolves on its own within a year in roughly two-thirds of cases. Oral lichen planus is a different story: spontaneous remission happens in fewer than about three to seven percent of cases, and the erosive form essentially does not resolve without treatment. The reticular (lace-like, white-patterned) form has the best outlook, with spontaneous remission occurring in about forty percent of cases.32JAMA Network. Treatment of Lichen Planus: An Evidence-Based Medicine Analysis of Efficacy
For drug-induced cases, removing the offending medication often leads to clearance, though it can take months. For hepatitis C-associated cases, treating the underlying viral infection may improve the lichen planus, though not always completely. And for the many cases with no single identifiable trigger, management tends to focus on suppressing the immune attack with topical corticosteroids or, in more severe cases, systemic immunosuppressants. This is where the multifactorial nature of the disease becomes most relevant to the person living with it: finding and addressing a specific cause, when one exists, generally leads to better outcomes than open-ended immune suppression alone.